Delek Insider Dumps 4,909: Should You Sell Now, Investors?
A blockbuster year for Delek US Holdings brought attention to a notable insider move. The event described as delek in...
See a global view of dividend ETFs and understand which regions offer the strongest yields, risk, and diversification for your strategy.
10,327 articlesA blockbuster year for Delek US Holdings brought attention to a notable insider move. The event described as delek in...
When a familiar tech name moves lower mid-session, investors want answers. This guide breaks down why intel stock dro...
You don't need a fortune to follow Warren Buffett's philosophy. With $300, you can start a durable, moat-rich lineup ...
Thinking about a 20-year horizon? Here are two high-quality picks I’d stake my plan on, with clear reasons, real-worl...
Apple sits around $284 as traders weigh the next move. A robust quarter and expanding Services set the stage for a bu...
Looking ahead two decades can feel daunting, but some stocks stand out as reliable winners. This guide reveals three ...
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Disney has debated separating its Parks division as the media world reshapes itself. This article explains whether a ...
Abbott Laboratories and Pfizer both delivered solid Q1 2026 numbers, yet the market sentiment diverged. Abbott slumpe...
Warren Buffett hands the CEO role to Greg Abel, shifting Berkshire Hathaway's guard and fueling a debate about whethe...
When energy costs rise, the economy can slow in surprising ways. This guide explains the link between rising prices a...
Apple doubles down on returning capital to shareholders with a $100 billion buyback and a dividend hike, while rivals...